+5 Ozagrel is an antiplatelet medication and selective thromboxane A₂ synthesis inhibitor used mainly to manage cerebrovascular and respiratory conditions. Its injection form is used to treat cerebral ischemia, thrombosis, and movement disorders, while oral formulations are prescribed to manage bronchial asthma. It is grouped under the following drug class(es): Antiplatelets. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ozagrelum and Cataclot. Its PubChem CID is 5282440.
Ozagrel
| CAS No | 82571-53-7 |
|---|---|
| Molecular Formula | C13H12N2O2 |
| Molecular Weight | 228.25 g/mol |
| Synonyms | (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
+5 Ozagrel is an antiplatelet medication and selective thromboxane A₂ synthesis inhibitor used mainly to manage cerebrovascular and respiratory conditions. Its injection form is used to treat cerebral ischemia, thrombosis, and movement disorders, while oral formulations are prescribed to manage bronchial asthma.
The listed CAS number is 82571-53-7.
The listed molecular formula is C13H12N2O2.
The listed molecular weight is 228.25 g/mol.
(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid.
The source lists Ozagrelum and Cataclot.